FDA, EMA Officials Stress Potential For FDA, EMA Collaboration On Generic Drug Review

CHICAGO -- FDA and the European Medicines Agency may begin working together on tackling issues related to generic drugs, according to one of FDA's top European liaisons. The FDA official stressed that while there are not currently ongoing dialogues between the EU and U.S. on generics, those discussions might begin as FDA Commissioner Scott Gottlieb continues his push for more generic competition as an answer to drug pricing. One EMA official added that complex generics and bioequivalence are two areas...